semaglutide vs liraglutide structure File:Semaglutide vs. v01 SVK.png File:Semaglutide vs. liraglutide v01.svg -
Description
Why this matters: SIRT-1 Downstream Effects
Major cardiovascular outcome trials and real-life observations have proven that glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), regardless of structural GLP-1 homology, exert clinically relevant cardiovascular protection
Previewing seven clinical trials focusing on obesity/weight loss that are anticipated to complete with the next 20 months.
Learn why you may not be seeing results and when to talk to a healthcare provider.
Explore the financial impact of GLP-1 medications
